[Ip-health] CBC News & Marc-Andre Gagnon: Biologics deal could raise healthcare costs

Peter Maybarduk pmaybarduk at citizen.org
Thu Sep 6 12:39:53 PDT 2018


Why it is worth keeping an eye on pharmaceuticals in NAFTA talks

U.S. has pushed for stronger protections on biologic drugs, which could raise costs in Canada
CBC News · Posted: Aug 30, 2018 7:25 PM ET | Last Updated: August 31

Canada's trade negotiators reportedly pushed back on a single bullet point about the new trade deal between the U.S. and Mexico that a health policy expert says could boost prescription drug costs for Canadian patients.

The U.S. trade representative's fact sheet on the new deal that was revealed Monday says it will "require at least 10 years of data protection for biologic drugs."

Increasing the protection to 10 years "is a big thing that will have an important impact on drug cost in Canada, especially in the context when we're discussing the implementation of a national pharmacare system in Canada," according to Marc-André​ Gagnon, a pharmaceutical policy researcher at Carleton University in Ottawa who has researched data protection in trade agreements. 

More: https://www.cbc.ca/news/health/nafta-pharmaceuticals-1.4805601

More information about the Ip-health mailing list